IGF2BP2 and diffuse large B-cell lymphoma: These results indicate that ouabain affects the malignant progression of DLBCL by influencing the m6A demethylase ALKBH5 and the m6A-binding protein IGF2BP2, suggesting that ALKBH5 and IGF2BP2 may be potential targets of ouabain action.